Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study

Fig. 1

BMMC treatment significantly improved the outcome of femoral heads at early-stage ONFH in SCD. ae Changes in HHS for femoral heads grouped according to Ficat stage over the entire postoperative period. Floating bars represent maximum and minimum range of variation, with lines at mean HHS. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, versus preoperative HHS values

Back to article page